PCG - This Stock Is Up More Than 800% in 10 Years: Is It Still a Buy?
Science and engineering consultancy Exponent (NASDAQ: EXPO) has massively outperformed the S&P 500 over the last decade with an 836% rise at the time of this writing. It's one of those businesses that, with the benefit of hindsight, seem like such an obvious investment idea: The company's engineers and scientists are known for analyzing the cause of accidents and failures. But is its stock still a good value? Let's look at this question in light of its recent third-quarter earnings.
Exponent prides itself on having 50% of its staff holding a Ph.D. or M.D. in their chosen field of study. It's a statistic that attests to the core strength of the company: its intellectual capital. In a nutshell, Exponent is a play on the increase in the intellectual quotient of goods and services.
Image source: Getty Images.